Elixinol Wellness Ltd
F:E8M
Elixinol Wellness Ltd
F:E8M
Price:
0.0045
EUR
12.5%
Market Closed
Market Cap:
€5.9m
Balance Sheet
Balance Sheet Decomposition
Elixinol Wellness Ltd
Elixinol Wellness Ltd
Balance Sheet Decomposition is not available for
Elixinol Wellness Ltd
Elixinol Wellness Ltd
Balance Sheet
Elixinol Wellness Ltd
Elixinol Wellness Ltd
Currency: AUD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
19
|
43
|
20
|
28
|
13
|
3
|
1
|
1
|
|
| Cash |
0
|
0
|
0
|
28
|
13
|
3
|
1
|
1
|
|
| Cash Equivalents |
19
|
43
|
20
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
3
|
2
|
2
|
4
|
4
|
2
|
2
|
|
| Accounts Receivables |
1
|
3
|
2
|
1
|
1
|
2
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
3
|
2
|
0
|
0
|
|
| Inventory |
2
|
7
|
21
|
5
|
2
|
2
|
4
|
4
|
|
| Other Current Assets |
1
|
4
|
8
|
1
|
1
|
1
|
2
|
1
|
|
| Total Current Assets |
23
|
57
|
51
|
35
|
20
|
9
|
8
|
7
|
|
| PP&E Net |
1
|
6
|
17
|
4
|
2
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
4
|
2
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
8
|
9
|
5
|
6
|
0
|
|
| Intangible Assets |
81
|
86
|
40
|
1
|
0
|
0
|
2
|
6
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
5
|
8
|
2
|
3
|
3
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
4
|
0
|
0
|
0
|
0
|
4
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
105
N/A
|
154
+47%
|
121
-22%
|
42
-65%
|
25
-40%
|
13
-47%
|
12
-13%
|
18
+58%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
6
|
3
|
2
|
1
|
1
|
2
|
2
|
|
| Accrued Liabilities |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
|
| Total Current Liabilities |
2
|
7
|
6
|
5
|
5
|
3
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
4
|
2
|
1
|
1
|
0
|
1
|
|
| Deferred Income Tax |
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Liabilities |
6
N/A
|
11
+81%
|
10
-10%
|
7
-29%
|
6
-8%
|
4
-31%
|
5
+21%
|
8
+60%
|
|
| Equity | |||||||||
| Common Stock |
102
|
140
|
189
|
218
|
218
|
218
|
223
|
228
|
|
| Retained Earnings |
3
|
4
|
77
|
190
|
208
|
218
|
225
|
218
|
|
| Other Equity |
0
|
0
|
0
|
8
|
9
|
9
|
9
|
0
|
|
| Total Equity |
99
N/A
|
144
+45%
|
111
-22%
|
36
-68%
|
19
-46%
|
9
-52%
|
6
-29%
|
10
+55%
|
|
| Total Liabilities & Equity |
105
N/A
|
154
+47%
|
121
-22%
|
42
-65%
|
25
-40%
|
13
-47%
|
12
-13%
|
18
+58%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
19
|
23
|
25
|
50
|
50
|
50
|
100
|
221
|
|
Switch to:
Switch to:
See Also
Discover More
